Bio-Rad Laboratories, Inc. (BIO-B) Stock Forecast
BIO-B analyst forecast
as of October 17, 2026- Analyst consensus
- —
- Price target
- — average of analyst targets
- Upside to target
- — from the latest close
- Next earnings
- —
- 52-week range
- $255.54 – $365.08
BIO-B revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $650.0M | $647.8M | $652.1M | −0.5% | 2 |
| Current fiscal year (2026) | $2.57B | $2.53B | $2.59B | −0.5% | 3 |
| Next fiscal year (2027) | $2.62B | $2.53B | $2.67B | +2.1% | 3 |
BIO-B EPS: reported and forecast
Reported EPSEstimate (average; low–high)
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BIO-B revenue: reported and forecast
Reported revenueEstimate (average; low–high)
BIO-B earnings surprises
Reported EPSEstimate
Reported EPS vs the consensus estimate for the last 12 quarters; BIO-B beat in 2 of 3.
What analysts expect from BIO-B
Bio-Rad Laboratories beat the EPS estimate in 2 of the last 3 quarters.
Related: BIO-B income statement, BIO-B key metrics, BIO-B chart. See the BIO-B stock overview for the latest quote and news.
BIO-B forecast FAQ
What is Bio-Rad Laboratories's revenue forecast?
The average revenue estimate for 2026 is $2.6 billion, growth of −0.5%; for 2027 it is $2.6 billion.
Does Bio-Rad Laboratories usually beat earnings estimates?
Bio-Rad Laboratories reported EPS at or above the analyst estimate in 2 of the last 3 quarters.